Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Sabra Healthcare REIT, Inc. SBRA

Growth Flags show if company had growth for consecutive years

Financial statements are limited to most recent four years or quarters for non-powerpack users

Ten years worth of data (where available), most important trends and XLS exports are available for our Powerpack users.
An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
Dec '24
Dec '25
Revenue
260.53
408.28
623.41
661.74
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Revenue Growth
9.07%
56.71%
52.69%
6.15%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Gross Profit
260.53
408.28
623.41
661.74
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
SG&A Expenses
17.67
32.40
37.09
30.89
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Operating Income
132.13
195.44
304.90
217.77
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Non-operating Income/Expense
(60.87)
(36.43)
(17.34)
(138.56)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Non-operating Interest Expenses
64.87
88.44
147.11
126.61
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Investment Gain/Loss (Other)
(5.43)
(6.80)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EBT
71.25
159.02
287.56
79.22
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Income Tax Provision
1.05
0.65
3.01
3.40
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Income after Tax
70.21
158.37
284.55
75.81
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Dividends (Preferred)
10.24
10.24
9.77
0.00
‡‡‡
Non-Controlling Interest
(0.07)
(0.02)
0.03
0.02
‡‡‡‡‡
Net Income Common
60.03
148.14
269.31
69.00
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EPS (Basic)
0.92
1.40
1.51
0.37
‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡
‡‡‡‡
‡‡‡‡
EPS (Diluted)
0.92
1.40
1.51
0.37
‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡
‡‡‡‡
‡‡‡‡
Shares (Basic, Weighted)
65.28
105.62
178.31
187.17
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Shares (Diluted, Weighted)
65.52
105.84
178.72
188.13
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Gross Margin
100.00%
100.00%
100.00%
100.00%
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
EBIT Margin
50.72%
47.87%
48.91%
32.91%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EBT margin
27.35%
38.95%
46.13%
11.97%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Net Profit Margin
23.04%
36.28%
43.20%
10.43%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Free Cash Flow Margin
45.81%
(34.49%)
72.82%
94.44%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EBITDA
200.60
309.33
496.28
399.32
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EBIT
132.13
195.44
304.90
217.77
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Income from Continuous Operations
70.21
158.37
279.12
69.02
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Consolidated Net Income/Loss
70.21
158.37
279.12
69.02
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EPS (Basic, from Continuous Ops)
1.08
1.50
1.57
0.37
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EPS (Basic, Consolidated)
1.08
1.50
1.57
0.37
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EPS (Diluted, from Cont. Ops)
1.07
1.50
1.56
0.37
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Shares (Diluted, Average)
65.52
105.84
178.72
188.13
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EPS (Diluted, Consolidated)
1.07
1.50
1.56
0.37
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EBITDA Margin
77.00%
75.76%
79.61%
60.34%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Operating Cash Flow Margin
67.53%
33.26%
57.84%
56.29%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡
© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us